FDA panel supports over-the-counter birth control pill, paving way for final, US approval

In a unanimous vote, the FDA advisers supported pharmaceutical manufacturer Perrigo’s request to sell its daily birth control pill, Opill, over the counter.
The recommendation is non-binding, but if the FDA follows it, then Opill would become the first contraceptive medication to be moved from a prescription-only basis to the store shelves. [ Source: Just the News (Read More…) ]
Worthy News reports from a biblical worldview with a commitment to accuracy, transparency, and editorial independence. Learn more about About Worthy News, our Editorial Standards, AI Use Policy, Ownership of Worthy News, News Tips and Corrections, and Worthy News Staff.
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌
